Brisse M, Hickman H
Microorganisms. 2025; 13(2).
PMID: 40005808
PMC: 11858409.
DOI: 10.3390/microorganisms13020443.
Wang N, Tian W, Zhao J, Wang W, Mi F
Medicine (Baltimore). 2025; 104(7):e41461.
PMID: 39960961
PMC: 11835109.
DOI: 10.1097/MD.0000000000041461.
Qian S, Long Y, Tan G, Li X, Xiang B, Tao Y
MedComm (2020). 2024; 5(12):e70024.
PMID: 39619229
PMC: 11604731.
DOI: 10.1002/mco2.70024.
Magnusen A, Pandey M
Int J Mol Sci. 2024; 25(22).
PMID: 39596318
PMC: 11594573.
DOI: 10.3390/ijms252212252.
Bhatt D, Janzen T, Daemen T, Weissing F
Sci Rep. 2024; 14(1):28861.
PMID: 39572761
PMC: 11582614.
DOI: 10.1038/s41598-024-80542-8.
CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays.
Cho Y, Laird M, Bishop T, Li R, Jazwinska D, Ruffo E
APL Bioeng. 2024; 8(3):036105.
PMID: 39049849
PMC: 11268919.
DOI: 10.1063/5.0207941.
PD-1 knockout on cytotoxic primary murine CD8 T cells improves their motility in retrovirus infected mice.
Mittermuller D, Otto L, Kilian A, Schnormeier A, Littwitz-Salomon E, Hasenberg A
Front Immunol. 2024; 15:1338218.
PMID: 38742109
PMC: 11089113.
DOI: 10.3389/fimmu.2024.1338218.
Cancer-on-a-chip model shows that the adenomatous polyposis coli mutation impairs T cell engagement and killing of cancer spheroids.
Bonnet V, Maikranz E, Madec M, Vertti-Quintero N, Cuche C, Mastrogiovanni M
Proc Natl Acad Sci U S A. 2024; 121(11):e2316500121.
PMID: 38442157
PMC: 10945811.
DOI: 10.1073/pnas.2316500121.
Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.
Menendez J, Cuyas E, Encinar J, Steen T, Verdura S, Llop-Hernandez A
Mol Oncol. 2023; 18(3):479-516.
PMID: 38158755
PMC: 10920094.
DOI: 10.1002/1878-0261.13582.
Heterogeneity in killing efficacy of individual effector CD8 T cells against Plasmodium liver stages.
Bera S, Amino R, Cockburn I, Ganusov V
Proc Biol Sci. 2023; 290(2011):20232280.
PMID: 38018100
PMC: 10685130.
DOI: 10.1098/rspb.2023.2280.
Quantitative analyses of T cell motion in tissue reveals factors driving T cell search in tissues.
Torres D, Mrass P, Byrum J, Gonzales A, Martinez D, Juarez E
Elife. 2023; 12.
PMID: 37870221
PMC: 10672806.
DOI: 10.7554/eLife.84916.
Cytotoxic T lymphocytes require transcription for infiltration but not target cell lysis.
Richard A, Ma C, Marioni J, Griffiths G
EMBO Rep. 2023; 24(11):e57653.
PMID: 37860838
PMC: 10626425.
DOI: 10.15252/embr.202357653.
Cytotoxic T Lymphocytes Control Growth of B16 Tumor Cells in Collagen-Fibrin Gels by Cytolytic and Non-Lytic Mechanisms.
Majumder B, Budhu S, Ganusov V
Viruses. 2023; 15(7).
PMID: 37515143
PMC: 10384826.
DOI: 10.3390/v15071454.
Regulatory T cells suppress the motility of cytotoxic T cells in Friend retrovirus-infected mice.
Mittermuller D, Otto L, Long Z, Kraus A, Beer A, Hasenberg A
JCI Insight. 2023; 8(13).
PMID: 37427590
PMC: 10371334.
DOI: 10.1172/jci.insight.167482.
Human T cells efficiently control RSV infection.
De C, Pickles R, Yao W, Liao B, Boone A, Choi M
JCI Insight. 2023; 8(11).
PMID: 37159271
PMC: 10393221.
DOI: 10.1172/jci.insight.168110.
Mathematical modeling suggests cytotoxic T lymphocytes control growth of B16 tumor cells in collagin-fibrin gels by cytolytic and non-lytic mechanisms.
Majumder B, Budhu S, Ganusov V
bioRxiv. 2023; .
PMID: 37034693
PMC: 10081166.
DOI: 10.1101/2023.03.28.534600.
Bucket lists must be completed during cell death.
Nozaki K, Miao E
Trends Cell Biol. 2023; 33(9):803-815.
PMID: 36958996
PMC: 10440244.
DOI: 10.1016/j.tcb.2023.02.008.
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment.
Ji Y, Madrasi K, Knee D, Gruenbaum L, Apgar J, Burke J
CPT Pharmacometrics Syst Pharmacol. 2023; 12(3):413-424.
PMID: 36710369
PMC: 10014051.
DOI: 10.1002/psp4.12925.
ALFA-PRF: a novel approach to detect murine perforin release from CTLs into the immune synapse.
Rudd-Schmidt J, Laine R, Noori T, Brennan A, Voskoboinik I
Front Immunol. 2023; 13:931820.
PMID: 36618385
PMC: 9813862.
DOI: 10.3389/fimmu.2022.931820.
Sources of inter-individual variability leading to significant changes in anti-PD-1 and anti-PD-L1 efficacy identified in mouse tumor models using a QSP framework.
Leete J, Zager M, Musante C, Shtylla B, Qiao W
Front Pharmacol. 2022; 13:1056365.
PMID: 36545310
PMC: 9760747.
DOI: 10.3389/fphar.2022.1056365.